Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Cell biology: a key driver of therapeutic innovation.

Hantschel O, Superti-Furga G.

J Cell Biol. 2012 Nov 12;199(4):571-5. doi: 10.1083/jcb.201208111.

PMID:
23148230
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Challenges and opportunities for drug discovery in psychiatric disorders: the drug hunters' perspective.

Wong EH, Yocca F, Smith MA, Lee CM.

Int J Neuropsychopharmacol. 2010 Oct;13(9):1269-84. doi: 10.1017/S1461145710000866. Epub 2010 Aug 18. Review.

PMID:
20716397
[PubMed - indexed for MEDLINE]
3.

New strategies in peripheral T-cell lymphoma: understanding tumor biology and developing novel therapies.

Dunleavy K, Piekarz RL, Zain J, Janik JE, Wilson WH, O'Connor OA, Bates SE.

Clin Cancer Res. 2010 Dec 1;16(23):5608-17. doi: 10.1158/1078-0432.CCR-09-1995. Review.

PMID:
21138864
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Collaborative approaches to anticancer drug discovery and development: a Cancer Research UK perspective.

Williams RJ, Walker I, Takle AK.

Drug Discov Today. 2012 Mar;17(5-6):185-7. doi: 10.1016/j.drudis.2012.01.020. Epub 2012 Jan 31.

PMID:
22314099
[PubMed - indexed for MEDLINE]
5.

Can open-source drug R&D repower pharmaceutical innovation?

Munos B.

Clin Pharmacol Ther. 2010 May;87(5):534-6. doi: 10.1038/clpt.2010.26. Review.

PMID:
20407458
[PubMed - indexed for MEDLINE]
6.

Cardiovascular drug discovery in the academic setting: building infrastructure, harnessing strengths, and seeking synergies.

Gardell SJ, Roth GP, Kelly DP.

J Cardiovasc Transl Res. 2010 Oct;3(5):431-7. doi: 10.1007/s12265-010-9204-8. Epub 2010 Jul 13.

PMID:
20625868
[PubMed - indexed for MEDLINE]
7.

Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.

Gaspar R, Aksu B, Cuine A, Danhof M, Takac MJ, Linden HH, Link A, Muchitsch EM, Wilson CG, Ohrngren P, Dencker L.

Eur J Pharm Sci. 2012 Dec 18;47(5):979-87. doi: 10.1016/j.ejps.2012.09.020. Epub 2012 Oct 6.

PMID:
23046836
[PubMed - indexed for MEDLINE]
8.

How to create innovation by building the translation bridge from basic research into medicinal drugs: an industrial perspective.

Germann PG, Schuhmacher A, Harrison J, Law R, Haug K, Wong G.

Hum Genomics. 2013 Mar 5;7:5. doi: 10.1186/1479-7364-7-5.

PMID:
23496921
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

AstraZeneca Pharmaceuticals enables scientific innovation.

[No authors listed]

Cardiovasc J Afr. 2014 Jan-Feb;25(1):40. No abstract available.

PMID:
24626520
[PubMed - indexed for MEDLINE]
Free Article
10.

[Biomarkers: "Found in translation"].

Lockhart BP, Walther B.

Med Sci (Paris). 2009 Apr;25(4):423-30. doi: 10.1051/medsci/2009254423. Review. French.

PMID:
19409197
[PubMed - indexed for MEDLINE]
Free Article
11.

The future is much closer collaboration between the pharmaceutical industry and academic medical centers.

Vallance P, Williams P, Dollery C.

Clin Pharmacol Ther. 2010 May;87(5):525-7. doi: 10.1038/clpt.2010.29. Review. No abstract available.

PMID:
20407455
[PubMed - indexed for MEDLINE]
12.

Pursuit of personalized anticancer therapy: leveraging collaboration between academia and the biotech/pharmaceutical industry.

Buck E, Mulvihill M, Iwata KK.

Mt Sinai J Med. 2010 Jul-Aug;77(4):358-65. doi: 10.1002/msj.20195. Review.

PMID:
20687181
[PubMed - indexed for MEDLINE]
13.

Drug discovery in a multidimensional world: systems, patterns, and networks.

Dudley JT, Schadt E, Sirota M, Butte AJ, Ashley E.

J Cardiovasc Transl Res. 2010 Oct;3(5):438-47. doi: 10.1007/s12265-010-9214-6. Epub 2010 Jul 31.

PMID:
20677029
[PubMed - indexed for MEDLINE]
14.

The future of discovery chemistry: quo vadis? Academic to industrial--the maturation of medicinal chemistry to chemical biology.

Hoffmann T, Bishop C.

Drug Discov Today. 2010 Apr;15(7-8):260-4. doi: 10.1016/j.drudis.2010.02.002. Epub 2010 Feb 10.

PMID:
20149893
[PubMed - indexed for MEDLINE]
15.

Impact of non-profit organizations on drug discovery: opportunities, gaps, solutions.

Matter A, Keller TH.

Drug Discov Today. 2008 Apr;13(7-8):347-52. doi: 10.1016/j.drudis.2008.02.005. Review.

PMID:
18405848
[PubMed - indexed for MEDLINE]
16.

Horizon scanning for novel therapeutics for the treatment of prostate cancer.

Bianchini D, Zivi A, Sandhu S, de Bono JS.

Ann Oncol. 2010 Oct;21 Suppl 7:vii43-55. doi: 10.1093/annonc/mdq369. Review.

PMID:
20943642
[PubMed - indexed for MEDLINE]
Free Article
17.

Molecularly targeted therapies for colorectal cancer: Strategies for implementing translational research in clinical trials.

Zwierzina H, Bardelli A, Ciardiello F, Gariboldi M, HÃ¥kansson L, Lambrechts D, Lind GE, Loeffler-Ragg J, Schmoll H, Siena S, Tabernero J, Van Cutsem E.

Curr Opin Mol Ther. 2010 Dec;12(6):703-11. Review.

PMID:
21154162
[PubMed - indexed for MEDLINE]
18.

Translational research in the pharmaceutical industry: from bench to bedside.

O'Connell D, Roblin D.

Drug Discov Today. 2006 Sep;11(17-18):833-8.

PMID:
16935752
[PubMed - indexed for MEDLINE]
19.

Grants4Targets - an innovative approach to translate ideas from basic research into novel drugs.

Lessl M, Schoepe S, Sommer A, Schneider M, Asadullah K.

Drug Discov Today. 2011 Apr;16(7-8):288-92. doi: 10.1016/j.drudis.2010.11.013. Epub 2010 Dec 1. Review.

PMID:
21129498
[PubMed - indexed for MEDLINE]
20.

On being a neurologist in industry.

Leppert D, Glanzman R.

Ann Neurol. 2013 Mar;73(3):319-26. doi: 10.1002/ana.23812. Epub 2013 Feb 19.

PMID:
23423974
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk